415 related articles for article (PubMed ID: 28042340)
1. Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.
Fan B; Kang L; Chen L; Sun P; Jin M; Wang Q; Bae YH; Huang W; Gao Z
Theranostics; 2017; 7(2):357-376. PubMed ID: 28042340
[TBL] [Abstract][Full Text] [Related]
2. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
[TBL] [Abstract][Full Text] [Related]
3. pH-Activated Targeting Drug Delivery System Based on the Selective Binding of Phenylboronic Acid.
Zhao D; Xu JQ; Yi XQ; Zhang Q; Cheng SX; Zhuo RX; Li F
ACS Appl Mater Interfaces; 2016 Jun; 8(23):14845-54. PubMed ID: 27229625
[TBL] [Abstract][Full Text] [Related]
4. ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy.
Zhou Z; Zhang Q; Zhang M; Li H; Chen G; Qian C; Oupicky D; Sun M
Theranostics; 2018; 8(17):4604-4619. PubMed ID: 30279726
[TBL] [Abstract][Full Text] [Related]
5. Phenylboronic acid-sugar grafted polymer architecture as a dual stimuli-responsive gene carrier for targeted anti-angiogenic tumor therapy.
Kim J; Lee YM; Kim H; Park D; Kim J; Kim WJ
Biomaterials; 2016 Jan; 75():102-111. PubMed ID: 26491998
[TBL] [Abstract][Full Text] [Related]
6. Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.
Yu H; Guo C; Feng B; Liu J; Chen X; Wang D; Teng L; Li Y; Yin Q; Zhang Z; Li Y
Theranostics; 2016; 6(1):14-27. PubMed ID: 26722370
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel.
Tang S; Yin Q; Su J; Sun H; Meng Q; Chen Y; Chen L; Huang Y; Gu W; Xu M; Yu H; Zhang Z; Li Y
Biomaterials; 2015 Apr; 48():1-15. PubMed ID: 25701027
[TBL] [Abstract][Full Text] [Related]
8. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
Song Y; Tang C; Yin C
Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
[TBL] [Abstract][Full Text] [Related]
10. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
[TBL] [Abstract][Full Text] [Related]
11. Reversible Shielding between Dual Ligands for Enhanced Tumor Accumulation of ZnPc-Loaded Micelles.
Cao J; Gao X; Cheng M; Niu X; Li X; Zhang Y; Liu Y; Wang W; Yuan Z
Nano Lett; 2019 Mar; 19(3):1665-1674. PubMed ID: 30801190
[TBL] [Abstract][Full Text] [Related]
12. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
13. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
[TBL] [Abstract][Full Text] [Related]
14. Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery.
Xu CF; Zhang HB; Sun CY; Liu Y; Shen S; Yang XZ; Zhu YH; Wang J
Biomaterials; 2016 May; 88():48-59. PubMed ID: 26945455
[TBL] [Abstract][Full Text] [Related]
15.
Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y
Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491
[TBL] [Abstract][Full Text] [Related]
16. Bioinspired nanoplatform for enhanced delivery efficiency of doxorubicin into nucleus with fast endocytosis, lysosomal pH-triggered drug release, and reduced efflux.
Huang Y; Xu Y; Wu Y; Chen T; Lu W; Yu J
Colloids Surf B Biointerfaces; 2019 Nov; 183():110413. PubMed ID: 31401461
[TBL] [Abstract][Full Text] [Related]
17. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
[TBL] [Abstract][Full Text] [Related]
19. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
[TBL] [Abstract][Full Text] [Related]
20. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
Fang L; Zhang W; Wang Z; Fan X; Cheng Z; Hou X; Chen D
Drug Deliv; 2019 Dec; 26(1):1125-1139. PubMed ID: 31736389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
